Min-Jeong Shin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Min-Jeong Shin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chang Deok Kim
Department of Dermatology, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, 35015, Republic of Korea; Department of Medical Science, Chungnam National University College of Medicine, Daejeon, 35015, Republic of Korea
1 shared publication - Dongkyun Hong
Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea
1 shared publication - Doyeon Kim
Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea
1 shared publication - Hyun-Sun Kim
Department of Dermatology, Soonchunhyang University Graduate School of Medicine, Asan 31538, Republic of Korea
1 shared publication - Jae Yun Kim
Department of Dermatology Soonchunhyang University Cheonan Hospital Cheonan South Korea
1 shared publication - Jung Eun Kim
Department of Dermatology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
1 shared publication
Latest Publications
- Open Access
- 21 December 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 167
Mechanistic Investigation of WWOX Function in NF-kB-Induced Skin Inflammation in Psoriasis
Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperproliferation, aberrant differentiation of keratinocytes, and dysregulated immune responses. WW domain-containing oxidoreductase (WWOX) is a non-classical tumor suppressor gene that regulates multiple cellular processes, including proliferation, apoptosis, and migration. This study aimed to explore the possible role of WWOX in the pathogenesis of psoriasis. Immunohistochemical analysis showed that the expression of WWOX was increased in epidermal keratinocytes of both human psoriatic lesions and imiquimod-induced mice psoriatic model. Immortalized human epidermal keratinocytes were transduced with a recombinant adenovirus expressing microRNA specific for WWOX to downregulate its expression. Inflammatory responses were detected using Western blotting, real-time quantitative reverse transcription polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay. In human epidermal keratinocytes, WWOX knockdown reduced nuclear factor-kappa B signaling and levels of proinflammatory cytokines induced by polyinosinic: polycytidylic acid [(poly(I:C)] in vitro. Furthermore, calcium chelator and protein kinase C (PKC) inhibitors significantly reduced poly(I:C)-induced inflammatory reactions. WWOX plays a role in the inflammatory reaction of epidermal keratinocytes by regulating calcium and PKC signaling. Targeting WWOX could be a novel therapeutic approach for psoriasis in the future.
- 21 December 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 167
Open AccessMechanistic Investigation of WWOX Function in NF-kB-Induced Skin Inflammation in Psoriasis
Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperproliferation, aberrant differentiation of keratinocytes, and dysregulated immune responses. WW domain-containing oxidoreductase (WWOX) is a non-classical tumor suppressor gene that regulates multiple cellular processes, including proliferation, apoptosis, and migration. This study aimed to explore the possible role of WWOX in the pathogenesis of psoriasis. Immunohistochemical analysis showed that the expression of WWOX was increased in epidermal keratinocytes of both human psoriatic lesions and imiquimod-induced mice psoriatic model. Immortalized human epidermal keratinocytes were transduced with a recombinant adenovirus expressing microRNA specific for WWOX to downregulate its expression. Inflammatory responses were detected using Western blotting, real-time quantitative reverse transcription polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay. In human epidermal keratinocytes, WWOX knockdown reduced nuclear factor-kappa B signaling and levels of proinflammatory cytokines induced by polyinosinic: polycytidylic acid [(poly(I:C)] in vitro. Furthermore, calcium chelator and protein kinase C (PKC) inhibitors significantly reduced poly(I:C)-induced inflammatory reactions. WWOX plays a role in the inflammatory reaction of epidermal keratinocytes by regulating calcium and PKC signaling. Targeting WWOX could be a novel therapeutic approach for psoriasis in the future.